Ligand Pharmaceuticals LGND Inventories
Inventories at other companies
Segments
By product
See fullOther financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ligand Pharmaceuticals's inventories?
- Ligand Pharmaceuticals (LGND) reported inventories of $13.27M in Q1 2026.
- How has Ligand Pharmaceuticals's inventories changed year-over-year?
- Ligand Pharmaceuticals's inventories decreased by 9.2% year-over-year, from $14.61M to $13.27M.
- What is the long-term trend for Ligand Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's inventories has grown at a -19.2% compound annual growth rate (CAGR), from $26.49M to $9.13M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.